Search for Clinical Trial Results

Autoimmune Hemolytic Anemia - 2 Studies Found

Status Study
Completed Study Name: A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
Condition: Warm Autoimmune Hemolytic Anemia
Date: 2026-05-11
Interventions: Obexelimab is a monoclonal antibody that simultaneously binds CD19 and Fc?RIIb, resulting in down regulation of B cell activity.
COMPLETED Study Name: A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Date: 2026-05-11
Interventions: Subjects will receive YTS109 cell, and dose escalation will commence at 5E6 cells/kg or the starting dose may be adjusted based on accumulated da